Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

THOUSAND OAKS, Calif., April 16, 2021 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prim... Biopharmaceuticals, Oncology, Mergers & Acquisitions Amgen, Five Prime Therapeutics, immunotherapy, targeted therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news